Feb 26 (Reuters) - Novavax raised its adjusted revenue forecast for 2026 on Thursday, banking on milestone payments from ...
Novavax’s alliance with Sanofi came at an opportune time for the beleaguered vaccine developer. Its protein-based Covid-19 vaccine never reached the revenue highs achieved by the messenger RNA ...
Q4 2025 Management View John Jacobs, President and CEO, stated that "we made significant progress on our corporate strategy in 2025, successfully executing against our existing partnerships while ...
Add Yahoo as a preferred source to see more of our stories on Google. A medical worker prepares ampoules of the Nuvaxovid vaccine against Covid-19 by Novavax at the Tegel vaccination center on ...
Recognized $625 million in primarily non-cash revenue in 2025 following the resolution of historical APA agreements with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results